The role of the kidney biopsy in the treatment of lupus nephritis

Renal Failure

Volumn 18, Issue 5, 1996, Pages 765-773

  Kashgarian, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; ELECTRON MICROSCOPY; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029864528     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229609047705     Document Type: Conference Paper

References (44)

1. Baldwin DS, Gluck GM, Lowenstein J, Gallo GR: Lupus nephritis: clinical causes as related to morphological forms and their transitions. Am J Med 62:12-30, 1977.
2. Comerford FR, Cohen AS: The nephropathy of systemic lupus erythematosus: an assessment of clinical, light and electron microscopic criteria. Medicine 46:425, 1967.
3. Baldwin DS, Lowenstein J, Rothfleld NF, Gallo GR, McCluskey RT: The clinical causes of the proliferative and membranous form of lupus nephritis. Ann Intern Med 73.929, 1970.
4. Pollack VE, Pirani CL: Renal histologic findings in systemic lupus erythematosus. Mayo Clin Proc 44:63, 1969.
5. Bennett WM, Bardana EJ, Houghton DC, Pirofsky B, Striker GD: Silent renal involvement in systemic lupus erythematosus. Int Arch Appl Immunol 55:420, 1977.
6. Eiser AR, Katz SM, Swartz C: Clinically occult diffuse proliferative lupus nephritis: an age-related phenomenon. Arch Intern Med 139:1023, 1979.
7. Magil AB, Putterman NL, Ballon HS, Chan V, Lirenman DS, Rae A, Sutton RAC: Prognostic factors in diffuse proliferative lupus glomerulonephritis. Kidney Int 34:511-517, 1988.
8. Woolf A, Croker B, Osafsky SG, Kredich DW: Nephritis in children and young adults with systemic lupus erythematosus and normal urinary sediment. Pediatrics 64:678, 1979.
9. Dixon FG: The pathogenesis of murine systemic lupus erythematosus. Am J Pathol 97:10, 1979.
10. Germuth FG, Rodriquez E: Immunopathology of the Renal Glomerulus. Boston: Little, Brown, 1973, pp. 15-44.
11. Johnson RJ, Couser WG, Chi EY, Adler S, Klebanott DJ. New mechanisms for glomerular injury: myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest 79:1379, 1987.
12. McCulloch KK, Powell J, Johnson KJ, Ward PA. Enhancement by platelets of oxygen radical responses of human neutrophils. Fed Proc 45:682, 1986.
13. McCluskey RT: Lupus nephritis. In Kidney Pathology. New York: Appleton-Century-Crofts, 1975, pp. 456-459.
14. Kashgarian M, Sterzel RB: The pathbiology of the mesangium. Kidney Int 41:524-529, 1992.
15. Vlahakos DV, Foster MH, Adams S. Katz M, Ucci AA, Barrett KJ, Datta SK, Madaio MP: Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int 41:1690-1700, 1992.
16. Termaat RM, Assmann KJM, Dijkman HBPM, Van Gompel F, Smeenk RJT, Berden JHM: Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms. Kidney Int 42:1363-1371, 1992.
17. Appel GB, Silva FG, Pirani CI, Meltzer JI, Estes D: Renal involvement in systemic lupus erythematosus. Medicine 57:371, 1978.
18. Hayslett JP, Kashgarian M, Cook CD, Spargo BH: The effect of azathioprine on lupus glomerulonephritis. Medicine 49:411, 1970.
19. Arishman E, Porush JC, Rosen SM, Chury J: Lupus nephritis with organized deposits in the kidneys. Nephron 10:25, 1973.
20. Kim YH, Choi YJ, Reiner L: Ultrastructural fingerprint in cryoprecipitate and glomerular deposits: a case report of systemic lupus erythematosus. Hum Pathol 12:86, 1991.
21. Riche SA: Human lupus inclusions and interferon. Science 213:772, 1981.
22. Johnson RJ, Alpers C, Pritzi P, Schulze N, Baker P, Oruchno C, Couser WG: Platelet-mediated neutrophildependent immune complex nephritis in the rat. J Clin Invest 82:1225, 1988.
23. Sakamoto H, Ooshima A: Activation of neutrophil phagocytosis of complement coated and IgG coated sheep erythrocytes by platelet release products. Br J Haematol 60:173, 1985.
24. Schmiedeke TMJ, Stockli FW, Weber R, Sugisaki Y, Batsford SR, Voat A: Histones have high affinity for the glomerular basement membrane. J Exp Med 169:1879-1894, 1989.
25. Nishikawa K, Guo YJ, Miyasaka M, Tamatani T, Collins AB, Sy MS, McCluskey RT, Andres G: Antibodies to ICAN-1/CFA-1 prevent crescent formations in rat autoimmune glomerulonephritis. J Exp Med 177:667-677, 1993.
26. Bruijn JA, Dincklo JCM: Distinct patterns of expression of ICAM-1, VCAM-1 and ELAM-1 in renal disease. Lab Invest 69:329-335, 1993.
27. Kant KS, Pollack VE, Weiss MA, Glueck HI, Miller AN, Hess EV: Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine 60:71, 1981.
28. Glas-Greenwalt P, Kant KS, Dosekum A, Frazier J, Allen C, Pollak VE: Ancrod: normalization of fibrinolytic enzyme abnormalities in patients with systemic lupus erythematosus and lupus nephritis. J Lab Clin Med 105:99, 1985.
29. Asherson RA, MacKorth-Young CG, Harris EN, Gharav AE, Hughes GR: Multiple venous and arterial thrombosis associated with the lupus anticoagulant and antibodies to cardiolipin in the absence of SLE. Rheumatol Int 5:91, 1985.
30. Banfi G, Bertani T, Boevi V, Faraggiana T, Mazzucco G, Monga G, Sacchi G: Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Am J Kidney Dis 28:240-248, 1991.
31. Esdaile JM, Levinton C, Federgreen W, Hayslett JP, Kashgarian M: The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature. Q J Med 269.779, 1989.
32. [GISNEL]: Lupus nephritis: prognostic factors and probability of maintaining life support renal function 10 years after the diagnosis Am J Kidney Dis 29:473-479, 1992.
33. Hecht B, Siegel NJ, Adler M, Kashgarian M, Hayslett JP: Prognostic indices in lupus nephritis. Medicine 55:163, 1976.
34. Esdaile JM, Federgreen W, Quintal H, Suissa S, Hayslett JP, Kashgarian M: Predictors of one year outcome in lupus nephritis: the importance of renal biopsy. Q J Med 295:907-918, 1991.
35. Esdaile JM, MacKenzie T, Barre P, Danott D, Osterland CK, Somerville P, Quintal H, Kashgarian M: Can experienced clinicians predict the outcome of lupus nephritis. Lupus 1:205-214, 1992.
36. Esdaile JM, Joseph L, MacKenzie T, Kashgarian M, Hayslett JP: The pathogenesis and prognosis of lupus nephritis: information from repeat renal biopsy. Semin Arthritis Rheum 23:135-145, 1993.
37. Esdaile JM, Abrahamowicz M, MacKenzie T, Hayslett JP. Kashgarian M: Time dependence of long term prediction in lupus nephritis. Arthritis Rheum 37:359-368, 1994.
38. Esdaile JM, Joseph L, MacKenzie T, Kashgarian M, Hayslett JP: The benefit of early treatment with immunosuppressive agents in lupus nephritis. J Rheumatol 21:2046-2050, 1994.
39. Dujovne I, Pollack VE, Pirani CI, Dillard MG: The distribution and character of glomerular deposits in systemic erythematosus. Kidney Int 2:33-50, 1972.
40. Austin HA, Muenz LR, Joyce KM, Antonovych T, Bacow JE: Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 25:689, 1984.
41. Whiting-O'Keefe Q, Henke JE, Shearn MA, Hopper J, Biava CG, Epstein WV: The information content from renal biopsy in systemic lupus erythematosus. Ann Intern Med 96:718-723, 1982.
42. Nossent HC, Henzer-Log SC, Vroom TM, Berden JHM, Swaak TJG: Contribution of renal biopsy data in predicting outcome in lupus nephritis. Arthritis Rheum 33:970-977, 1990.
43. Tateno S, Kobayashi Y, Shitematsu H, Hiki Y: Study of lupus nephritis: its classification and the significance of subendothelial deposits. Q J Med 52:311, 1983.
44. Cameron JS: Interstitial changes in glomerulonephritis. In Buccianti GM (ed), Prevention in Nephrology. Milan: Massion, 1987, pp. 8-18.